This inventor holds 1 USPTO granted patent. Top assignee: Intercept Pharmaceuticals, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Paul E. Whitley: Innovator in Bile Acid Derivatives
Introduction
Paul E. Whitley is a notable inventor based in Florence, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of bile acid derivatives. His innovative work has led to the development of methods and intermediates that are crucial for advancing medical treatments.
Latest Patents
Whitley holds a patent for "Methods and intermediates for the preparation bile acid derivatives." This invention relates to methods and novel intermediates useful in the preparation of a compound of formula (A) or a pharmaceutically acceptable salt thereof. The process involves converting the aldehyde of a compound of formula (B) with a reducing agent to prepare a compound of formula (C) and subsequently converting the compound of formula (C) with a sulfating reagent to prepare a compound of formula (A). The objective of this invention is to provide efficient methods for synthesizing bile acid derivatives that activate both FXR and TGR5. He has 1 patent to his name.
Career Highlights
Whitley is currently associated with Intercept Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is instrumental in developing new therapeutic options that can improve patient outcomes.
Collaborations
Throughout his career, Whitley has collaborated with talented individuals such as Flavio Chavez Lopez and Kayla R. Iorga. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Paul E. Whitley is a distinguished inventor whose work in bile acid derivatives has the potential to transform pharmaceutical applications. His contributions are vital for the advancement of medical science and patient care.
